Amexdrug Statistics
Total Valuation
Amexdrug has a market cap or net worth of 33,821.
| Market Cap | 33,821 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Amexdrug has 169.11 million shares outstanding.
| Current Share Class | 169.11M |
| Shares Outstanding | 169.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.20.
| PE Ratio | 0.20 |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.05 |
| P/TBV Ratio | 0.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.46.
| Current Ratio | 1.35 |
| Quick Ratio | 0.67 |
| Debt / Equity | 1.46 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | -1.79 |
| Interest Coverage | 6.93 |
Financial Efficiency
Return on equity (ROE) is 28.78% and return on invested capital (ROIC) is 12.82%.
| Return on Equity (ROE) | 28.78% |
| Return on Assets (ROA) | 11.25% |
| Return on Invested Capital (ROIC) | 12.82% |
| Return on Capital Employed (ROCE) | 34.43% |
| Weighted Average Cost of Capital (WACC) | 2.85% |
| Revenue Per Employee | 833,411 |
| Profits Per Employee | 15,076 |
| Employee Count | 11 |
| Asset Turnover | 4.99 |
| Inventory Turnover | 11.76 |
Taxes
In the past 12 months, Amexdrug has paid 120,227 in taxes.
| Income Tax | 120,227 |
| Effective Tax Rate | 42.03% |
Stock Price Statistics
The stock price has decreased by -90.00% in the last 52 weeks. The beta is -0.43, so Amexdrug's price volatility has been lower than the market average.
| Beta (5Y) | -0.43 |
| 52-Week Price Change | -90.00% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 32.66 |
| Average Volume (20 Days) | 2,891 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amexdrug had revenue of 9.17 million and earned 165,834 in profits. Earnings per share was 0.00.
| Revenue | 9.17M |
| Gross Profit | 1.27M |
| Operating Income | 330,933 |
| Pretax Income | 286,061 |
| Net Income | 165,834 |
| EBITDA | 380,827 |
| EBIT | 330,933 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 168,009 in cash and 961,115 in debt, with a net cash position of -793,106 or -0.00 per share.
| Cash & Cash Equivalents | 168,009 |
| Total Debt | 961,115 |
| Net Cash | -793,106 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 658,233 |
| Book Value Per Share | 0.00 |
| Working Capital | 456,846 |
Cash Flow
In the last 12 months, operating cash flow was -74,833 and capital expenditures -460,984, giving a free cash flow of -535,817.
| Operating Cash Flow | -74,833 |
| Capital Expenditures | -460,984 |
| Free Cash Flow | -535,817 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 13.80%, with operating and profit margins of 3.61% and 1.81%.
| Gross Margin | 13.80% |
| Operating Margin | 3.61% |
| Pretax Margin | 3.12% |
| Profit Margin | 1.81% |
| EBITDA Margin | 4.15% |
| EBIT Margin | 3.61% |
| FCF Margin | n/a |
Dividends & Yields
Amexdrug does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 490.33% |
| FCF Yield | -1,584.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 3, 2012. It was a forward split with a ratio of 20.
| Last Split Date | Dec 3, 2012 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
Amexdrug has an Altman Z-Score of 23.07 and a Piotroski F-Score of 3.
| Altman Z-Score | 23.07 |
| Piotroski F-Score | 3 |